Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-03-03

FDA Approved: SPIRIVA HANDIHALER — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Spiriva HandiHaler (tiotropium bromide) from Boehringer Ingelheim Pharmaceuticals, Inc. The approval updates the pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SPIRIVA HANDIHALER (TIOTROPIUM BROMIDE)

Snippet

SUPPL AP for SPIRIVA HANDIHALER (TIOTROPIUM BROMIDE)